Literature DB >> 24690081

Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.

Alejandro Gutierrez1, Hui Feng, Kristen Stevenson, Donna S Neuberg, Oscar Calzada, Yi Zhou, David M Langenau, A Thomas Look.   

Abstract

The TP53 tumour suppressor is activated in response to distinct stimuli, including an ARF-dependent response to oncogene stress and an ATM/ATR-dependent response to DNA damage. In human T-cell acute lymphoblastic leukaemia (T-ALL), TP53-dependent tumour suppression is typically disabled via biallelic ARF deletions. In murine models, loss of Arf (Cdkn2a) or Tp53 markedly accelerates the onset of Myc-induced lymphoblastic malignancies. In zebrafish, no ARF ortholog has been identified, but the sequence of ARF is very poorly conserved evolutionarily, making it difficult to exclude the presence of a zebrafish ARF ortholog without functional studies. Here we show that tp53 mutations have no significant influence on the onset of myc-induced T-ALL in zebrafish, consistent with the lack of additional effects of Tp53 loss on lymphomagenesis in Arf-deficient mice. By contrast, irradiation leads to complete T-ALL regression in tp53 wild-type but not homozygous mutant zebrafish, indicating that the tp53-dependent DNA damage response is intact. We conclude that tp53 inactivation has no impact on the onset of myc-induced T-ALL in the zebrafish, consistent with the lack of a functional ARF ortholog linking myc-induced oncogene stress to tp53-dependent tumour suppression. Thus, the zebrafish model is well suited to the study of ARF-independent pathways in T-ALL pathobiology.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  ARF; Myc; T-cell acute lymphoblastic leukaemia; Tp53; tumour suppression

Mesh:

Substances:

Year:  2014        PMID: 24690081      PMCID: PMC4234197          DOI: 10.1111/bjh.12851

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  44 in total

1.  Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Li Pan; Richard W J Groen; Frederic Baleydier; Alex Kentsis; Jason Marineau; Ruta Grebliunaite; Elena Kozakewich; Casie Reed; Francoise Pflumio; Sandrine Poglio; Benjamin Uzan; Paul Clemons; Lynn VerPlank; Frank An; Jason Burbank; Stephanie Norton; Nicola Tolliday; Hanno Steen; Andrew P Weng; Huipin Yuan; James E Bradner; Constantine Mitsiades; A Thomas Look; Jon C Aster
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

2.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.

Authors:  M Wada; C R Bartram; H Nakamura; M Hachiya; D L Chen; J Borenstein; C W Miller; L Ludwig; T E Hansen-Hagge; W D Ludwig
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

5.  Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.

Authors:  J Martín-Caballero; J M Flores; P García-Palencia; M Serrano
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.

Authors:  J Gilley; M Fried
Journal:  Oncogene       Date:  2001-11-01       Impact factor: 9.867

7.  Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase.

Authors:  M H Hsiao; A L Yu; J Yeargin; D Ku; M Haas
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

8.  Myc-induced T cell leukemia in transgenic zebrafish.

Authors:  David M Langenau; David Traver; Adolfo A Ferrando; Jeffery L Kutok; Jon C Aster; John P Kanki; Shuo Lin; Ed Prochownik; Nikolaus S Trede; Leonard I Zon; A Thomas Look
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

9.  Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Authors:  Frederique Zindy; Richard T Williams; Troy A Baudino; Jerold E Rehg; Stephen X Skapek; John L Cleveland; Martine F Roussel; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

10.  Absence of p16INK4a and truncation of ARF tumor suppressors in chickens.

Authors:  Soo-Hyun Kim; Michael Mitchell; Hideta Fujii; Susana Llanos; Gordon Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-27       Impact factor: 11.205

View more
  6 in total

Review 1.  Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.

Authors:  Nicholas R Harrison; Fabrice J F Laroche; Alejandro Gutierrez; Hui Feng
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.

Authors:  Marc R Mansour; Shuning He; Zhaodong Li; Riadh Lobbardi; Brian J Abraham; Clemens Hug; Sunniyat Rahman; Theresa E Leon; You-Yi Kuang; Mark W Zimmerman; Traci Blonquist; Evisa Gjini; Alejandro Gutierrez; Qin Tang; Laura Garcia-Perez; Karin Pike-Overzet; Lars Anders; Alla Berezovskaya; Yi Zhou; Leonard I Zon; Donna Neuberg; Adele K Fielding; Frank J T Staal; David M Langenau; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  J Exp Med       Date:  2018-06-25       Impact factor: 14.307

3.  Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model.

Authors:  Gilseung Park; Jessica Burroughs-Garcia; Clay A Foster; Ameera Hasan; Chiara Borga; J Kimble Frazer
Journal:  Oncotarget       Date:  2020-04-14

Review 4.  Modeling hematopoietic disorders in zebrafish.

Authors:  Martina Konantz; Christoph Schürch; Pauline Hanns; Joëlle S Müller; Loïc Sauteur; Claudia Lengerke
Journal:  Dis Model Mech       Date:  2019-09-06       Impact factor: 5.758

5.  Multi-Omics Analysis of Acute Lymphoblastic Leukemia Identified the Methylation and Expression Differences Between BCP-ALL and T-ALL.

Authors:  Jin-Fan Li; Xiao-Jing Ma; Lin-Lin Ying; Ying-Hui Tong; Xue-Ping Xiang
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 6.  Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer.

Authors:  David M Langenau; Alejandro Sweet-Cordero; Robert Wechsler-Reya; Michael A Dyer
Journal:  Cancer Res       Date:  2015-12-01       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.